Target intelligence / Profile preview

Ankyrin repeat domain 20 family member A9, pseudogene (ANKRD20A9P)

Target
ANKRD20A9P
Molecular classification
Other (Pseudogene)
01

Overview

ANKRD20A9P is a pseudogene, meaning it is a non-functional sequence in the genome that resembles a protein-coding gene but does not produce a functional protein[3][4][8]. Pseudogenes generally arise from duplication or retrotransposition events that introduce mutations or other disruptions, rendering them non-coding[5][6]. While some pseudogenes can regulate gene expression at the RNA level, for example by acting as decoys for microRNAs (competing endogenous RNAs) or precursors for small interfering RNAs, there is no evidence for such a function specifically attributed to ANKRD20A9P[5][6]. There are no known drug interactions, disease associations, or biomarker roles for this pseudogene. Gene databases and genomic resources list it as a well-annotated pseudogene without known protein-coding capacity or direct therapeutic relevance[3][4][8].

02

Mechanism of action

None reported; as a pseudogene, there is no canonical mechanism of action

03

Biological functions

Other (Potential regulation of gene expression through RNA-based mechanisms, as implied for pseudogenes in general)
04

Disease associations

Other (No direct disease association for ANKRD20A9P; some pseudogenes can play roles in gene regulation and disease, but this is not established for ANKRD20A9P specifically)

Beyond the preview

Go deeper on Ankyrin repeat domain 20 family member A9, pseudogene (ANKRD20A9P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ankyrin repeat domain 20 family member A9, pseudogene (ANKRD20A9P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call